GlassScriptPhysician profile
Firas Mourad
NPI 1932639077
$2,810.73
in general payments reported to CMS, 2019-2025
9 companies · $660 in 2025
The $660 reported for 2025 was more than what 82% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $916 · 2024: $1,235 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,554 · Food and Beverage: $772 · Gift: $419 · Entertainment: $65.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,554.05 |
| Food and Beverage | $772.42 |
| Gift | $418.98 |
| Entertainment | $65.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $988.85 | 2024 | Na |
| Midmark Corporation | $829.60 | 2023 | |
| Ultradent Products INC | $418.98 | 2025 | Opalescence |
| Zimvie INC. | $287.01 | 2024-2025 | |
| Straumann USA LLC | $93.07 | 2025 | |
| Dentsply Sirona INC | $90.57 | 2023-2024 | Primescan Connect, Cavitron, Implant Dentistry |
| Biohorizons Implant Systems INC. | $64.47 | 2023-2024 | Biohorizons |
| Align Technology, INC. | $22.73 | 2025 | Invisalign |
| Voco America INC. | $15.45 | 2023 | Bifix Qm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Firas Mourad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.